Healthy Extracts Inc Financials

HYEX

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows Healthy Extracts Inc (HYEX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Neutral

5/9

Healthy Extracts Inc passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

-0.34x

For every $1 of reported earnings, Healthy Extracts Inc generates $-0.34 in operating cash flow ($282K OCF vs -$841K net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Revenue

$3.1M

YoY+25.2%

5Y CAGR+33.0%

Healthy Extracts Inc generated $3.1M in revenue in fiscal year 2024. This represents an increase of 25.2% from the prior year.

EBITDA

N/A

Free Cash Flow

N/A

Net Income

-$841K

YoY+66.0%

Healthy Extracts Inc reported -$841K in net income in fiscal year 2024. This represents an increase of 66.0% from the prior year.

EPS (Diluted)

N/A

Cash & Debt

$112K

YoY+476.2%

5Y CAGR-3.4%

Healthy Extracts Inc held $112K in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

YoY+1.2%

Healthy Extracts Inc had 3M shares outstanding in fiscal year 2024. This represents an increase of 1.2% from the prior year.

Gross Margin

61.4%

YoY-3.8pp

5Y CAGR+31.5pp

Healthy Extracts Inc's gross margin was 61.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 3.8 percentage points from the prior year.

Operating Margin

N/A

Net Margin

-27.0%

YoY+72.5pp

5Y CAGR-111.5pp

Healthy Extracts Inc's net profit margin was -27.0% in fiscal year 2024, showing the share of revenue converted to profit. This is up 72.5 percentage points from the prior year.

Return on Equity

N/A

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

HYEX Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$3.1M+25.2%	$2.5M+10.4%	$2.3M+34.3%	$1.7M+29.0%	$1.3M+73.6%	$748K
Cost of Revenue	$1.2M+39.1%	$864K-1.8%	$880K+58.0%	$557K+19.8%	$465K+367.2%	$100K
Gross Profit	$1.9M+17.9%	$1.6M+18.2%	$1.4M+97.3%	$695K+220.2%	-$578K-358.4%	$224K
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$2.1M-45.8%	$3.9M+69.3%	$2.3M-11.7%	$2.6M+75.2%	$1.5M+26.7%	$1.2M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	-$186K-5.3%	-$177K-173.5%	-$65K-23.3%	-$52K+28.0%	-$73K+16.7%	-$87K
Income Tax	$0	$0	$0	N/A	N/A	N/A
Net Income	-$841K+66.0%	-$2.5M-151.5%	-$983K+50.5%	-$2.0M+22.9%	-$2.6M-507.2%	$633K
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Revenue	$918K-5.2%	$969K+4.0%	$931K+20.8%	$771K-15.1%	$908K+31.9%	$689K+3.0%	$669K+9.0%	$614K
Cost of Revenue	$471K+25.3%	$376K-25.8%	$506K+41.9%	$357K-15.5%	$422K+50.6%	$280K+171.7%	$103K-14.2%	$120K
Gross Profit	$447K-24.6%	$593K+39.5%	$425K+2.6%	$414K-14.7%	$486K+19.0%	$408K-27.8%	$566K+14.7%	$493K
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$907K+29.9%	$698K+30.8%	$534K-12.3%	$609K+22.3%	$498K+5.9%	$470K-47.0%	$888K+17.7%	$754K
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	-$56K-92.0%	-$29K+15.3%	-$35K+37.1%	-$55K-12.8%	-$49K-14.5%	-$43K-11.5%	-$38K-55.8%	-$25K
Income Tax	N/A	N/A	$0	N/A	N/A	$0	N/A	N/A
Net Income	-$395K-689.1%	$67K+116.8%	-$399K+10.8%	-$447K-494.2%	$114K+113.2%	-$861K-127.5%	-$379K-52.7%	-$248K
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

HYEX Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$2.4M-9.8%	$2.6M-5.3%	$2.8M-8.2%	$3.0M-2.8%	$3.1M-9.7%	$3.4M
Current Assets	$1.7M-12.6%	$1.9M-7.0%	$2.0M-11.7%	$2.3M-7.1%	$2.5M-23.2%	$3.2M
Cash & Equivalents	$112K+476.2%	$19K-70.4%	$66K-70.4%	$222K+275.2%	$59K-55.6%	$133K
Inventory	$1.4M-16.3%	$1.6M-10.6%	$1.8M-7.1%	$2.0M-19.0%	$2.4M-21.5%	$3.1M
Accounts Receivable	$11K-63.9%	$30K-71.2%	$106K-20.7%	$133K+904.5%	$13K-49.9%	$26K
Goodwill	$193K0.0%	$193K0.0%	$193K0.0%	$193K0.0%	$193K0.0%	$193K
Total Liabilities	$2.0M+22.2%	$1.6M+77.1%	$910K+62.8%	$559K+113.6%	$262K-93.9%	$4.3M
Current Liabilities	$1.3M-20.3%	$1.7M+86.1%	$903K+61.5%	$559K+113.6%	$262K-93.9%	$4.3M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$410K-59.9%	$1.0M-45.3%	$1.9M-24.3%	$2.5M-13.4%	$2.9M+429.7%	-$866K
Retained Earnings	-$19.2M-4.6%	-$18.4M-15.5%	-$15.9M-6.6%	-$14.9M-15.3%	-$13.0M-24.8%	-$10.4M

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Total Assets	$26.2M+949.5%	$2.5M+3.5%	$2.4M+1.4%	$2.4M-4.3%	$2.5M-4.6%	$2.6M-1.1%	$2.6M-0.2%	$2.6M
Current Assets	$1.7M+10.8%	$1.6M+5.4%	$1.5M-10.8%	$1.7M-5.1%	$1.7M-6.5%	$1.9M-1.6%	$1.9M-0.3%	$1.9M
Cash & Equivalents	$189K-5.5%	$200K+68.8%	$119K+6.1%	$112K-24.4%	$148K+69.8%	$87K+349.1%	$19K-58.1%	$46K
Inventory	$967K-12.7%	$1.1M-3.1%	$1.1M-16.1%	$1.4M+3.2%	$1.3M-15.0%	$1.6M-4.5%	$1.6M+6.5%	$1.5M
Accounts Receivable	$31K+685.5%	$4K-94.3%	$70K+536.0%	$11K-87.8%	$91K+276.5%	$24K-21.0%	$30K-72.1%	$109K
Goodwill	$193K0.0%	$193K0.0%	$193K0.0%	$193K0.0%	$193K0.0%	$193K0.0%	$193K0.0%	$193K
Total Liabilities	$2.1M+5.6%	$2.0M-14.2%	$2.4M+19.5%	$2.0M-5.6%	$2.1M-15.0%	$2.5M+52.3%	$1.6M-0.3%	$1.6M
Current Liabilities	$1.2M+36.2%	$862K-63.3%	$2.4M+75.5%	$1.3M-35.7%	$2.1M-15.0%	$2.5M+46.0%	$1.7M+4.0%	$1.6M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$24.1M+4934.2%	$478K+689.9%	$61K-85.3%	$410K+2.6%	$400K+163.8%	$152K-85.2%	$1.0M0.0%	$1.0M
Retained Earnings	-$20.0M-2.0%	-$19.6M+0.3%	-$19.6M-2.1%	-$19.2M-0.5%	-$19.1M+0.6%	-$19.3M-4.7%	-$18.4M-2.1%	-$18.0M

HYEX Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$282K+167.8%	-$416K-6.4%	-$391K+56.7%	-$901K+52.6%	-$1.9M-9.9%	-$1.7M
Capital Expenditures	N/A	$0-100.0%	$8K	$0	N/A	$23K
Free Cash Flow	N/A	-$416K-4.3%	-$399K+55.8%	-$901K	N/A	-$1.8M
Investing Cash Flow	$0	$0+100.0%	-$5K+94.4%	-$96K+17.1%	-$116K-305.5%	$56K
Financing Cash Flow	-$189K-151.3%	$370K+54.3%	$240K-79.4%	$1.2M-40.3%	$1.9M+7.6%	$1.8M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Operating Cash Flow	-$280K-1725.6%	$17K-71.3%	$60K+43.3%	$42K-75.2%	$169K+803.0%	$19K-66.3%	$56K+181.9%	-$68K
Capital Expenditures	N/A	N/A	N/A	N/A	$0	$0	$0	$0
Free Cash Flow	N/A	N/A	N/A	N/A	$169K+803.0%	$19K-66.3%	$56K+181.9%	-$68K
Investing Cash Flow	$0+100.0%	-$19K	$0	$0	$0	$0	$0	$0
Financing Cash Flow	$269K+220.9%	$84K+257.4%	-$53K-76.0%	-$30K+72.0%	-$108K-320.1%	$49K+159.5%	-$83K-479.3%	$22K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

HYEX Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	61.4%-3.8pp	65.2%+4.3pp	60.9%+19.5pp	41.5%+86.0pp	-44.5%-74.4pp	29.9%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-27.0%+72.5pp	-99.5%-55.8pp	-43.7%+74.9pp	-118.5%+79.7pp	-198.3%-282.8pp	84.5%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-35.4%+58.5pp	-93.8%-58.5pp	-35.4%+30.2pp	-65.6%+17.1pp	-82.7%-101.0pp	18.3%
Current Ratio	1.24+0.1	1.13-1.1	2.26-1.9	4.14-5.4	9.52+8.8	0.75
Debt-to-Equity	4.79+3.2	1.57+1.1	0.49+0.3	0.23+0.1	0.09+5.1	-4.99
FCF Margin	N/A	-16.7%+1.0pp	-17.7%+36.1pp	-53.8%	N/A	-234.3%

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Gross Margin	48.7%-12.5pp	61.2%+15.6pp	45.6%-8.1pp	53.7%+0.2pp	53.5%-5.8pp	59.3%-25.3pp	84.6%+4.2pp	80.4%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-43.1%-50.0pp	6.9%+49.8pp	-42.8%+15.2pp	-58.0%-70.5pp	12.5%+137.5pp	-125.0%-68.4pp	-56.6%-16.2pp	-40.4%
Return on Equity	N/A	14.0%	N/A	44.1%+15.8pp	28.4%	N/A	N/A	N/A
Return on Assets	-1.5%-4.2pp	2.7%+19.2pp	-16.5%+2.3pp	-18.8%-23.4pp	4.6%+37.6pp	-33.1%-18.7pp	-14.4%-5.0pp	-9.4%
Current Ratio	1.47-0.3	1.81+1.2	0.63-0.6	1.24+0.4	0.84+0.1	0.76-0.4	1.13-0.0	1.18
Debt-to-Equity	0.09-4.1	4.22-34.6	38.85+34.1	4.79-0.4	5.21-11.0	16.18+14.6	1.570.0	1.58
FCF Margin	N/A	N/A	N/A	N/A	18.6%+15.9pp	2.7%-5.6pp	8.3%+19.4pp	-11.1%

Similar Companies

MOBERG PHARMA AB PUBL MBGPF

$45.4M

Leef Brands LEEEF

$39.2M

Eagle Pharmaceut EGRX

$26.6M

C21 Investments CXXIF

$36.5M

Rubicon Organics ROMJF

$30.2M

Frequently Asked Questions

What is Healthy Extracts Inc's annual revenue?

Healthy Extracts Inc (HYEX) reported $3.1M in total revenue for fiscal year 2024. This represents a 25.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Healthy Extracts Inc's revenue growing?

Healthy Extracts Inc (HYEX) revenue grew by 25.2% year-over-year, from $2.5M to $3.1M in fiscal year 2024.

Is Healthy Extracts Inc profitable?

No, Healthy Extracts Inc (HYEX) reported a net income of -$841K in fiscal year 2024, with a net profit margin of -27.0%.

What is Healthy Extracts Inc's gross margin?

Healthy Extracts Inc (HYEX) had a gross margin of 61.4% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Healthy Extracts Inc's net profit margin?

Healthy Extracts Inc (HYEX) had a net profit margin of -27.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Healthy Extracts Inc's operating cash flow?

Healthy Extracts Inc (HYEX) generated $282K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Healthy Extracts Inc's total assets?

Healthy Extracts Inc (HYEX) had $2.4M in total assets as of fiscal year 2024, including both current and long-term assets.

How many shares does Healthy Extracts Inc have outstanding?

Healthy Extracts Inc (HYEX) had 3M shares outstanding as of fiscal year 2024.

What is Healthy Extracts Inc's current ratio?

Healthy Extracts Inc (HYEX) had a current ratio of 1.24 as of fiscal year 2024, which is considered adequate.

What is Healthy Extracts Inc's debt-to-equity ratio?

Healthy Extracts Inc (HYEX) had a debt-to-equity ratio of 4.79 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Healthy Extracts Inc's return on assets (ROA)?

Healthy Extracts Inc (HYEX) had a return on assets of -35.4% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Healthy Extracts Inc's Piotroski F-Score?

Healthy Extracts Inc (HYEX) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Healthy Extracts Inc's earnings high quality?

Healthy Extracts Inc (HYEX) has an earnings quality ratio of -0.34x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.